Discovering and validating cancer genetic dependencies: approaches and pitfalls
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovering and validating cancer genetic dependencies: approaches and pitfalls
Authors
Keywords
-
Journal
NATURE REVIEWS GENETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-19
DOI
10.1038/s41576-020-0247-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
- (2020) Kyuho Han et al. NATURE
- Massively parallel Cas13 screens reveal principles for guide RNA design
- (2020) Hans-Hermann Wessels et al. NATURE BIOTECHNOLOGY
- Cas9 activates the p53 pathway and selects for p53-inactivating mutations
- (2020) Oana M. Enache et al. NATURE GENETICS
- SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice
- (2019) Reham Ajina et al. OncoImmunology
- Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients
- (2019) Chodimella Chandrasekhar et al. Scientific Reports
- Target identification reveals lanosterol synthase as a vulnerability in glioma
- (2019) Richard E. Phillips et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
- (2019) Yves Depetter et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic compensation triggered by mutant mRNA degradation
- (2019) Mohamed A. El-Brolosy et al. NATURE
- Lethal clues to cancer-cell vulnerability
- (2019) Felix Y. Feng et al. NATURE
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
- (2019) Fiona M. Behan et al. NATURE
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
- (2019) Jumpei Kondo et al. Cells
- VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells
- (2019) Jesse C. Patterson et al. Cell Systems
- Reply to “CRISPR screens are feasible in TP53 wild‐type cells”
- (2019) Emma Haapaniemi et al. Molecular Systems Biology
- CRISPR screens are feasible in TP 53 wild‐type cells
- (2019) Kevin R Brown et al. Molecular Systems Biology
- Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
- (2019) Ann Lin et al. Science Translational Medicine
- Biological plasticity rescues target activity in CRISPR knock outs
- (2019) Arne H. Smits et al. NATURE METHODS
- Genome-scale CRISPR screens are efficient in non-homologous end-joining deficient cells
- (2019) Joana Ferreira da Silva et al. Scientific Reports
- Estimation of clinical trial success rates and related parameters
- (2018) Chi Heem Wong et al. BIOSTATISTICS
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
- (2018) Silvana Konermann et al. CELL
- Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
- (2018) Minan Wang et al. FASEB JOURNAL
- Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma
- (2018) Xiaohui Zhang et al. LEUKEMIA
- CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
- (2018) Emma Haapaniemi et al. NATURE MEDICINE
- Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
- (2018) Michael J. Thomenius et al. PLoS One
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- (2018) Georgios Vlachogiannis et al. SCIENCE
- Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes
- (2018) Jasper Edgar Neggers et al. Nature Communications
- The CRISPR tool kit for genome editing and beyond
- (2018) Mazhar Adli Nature Communications
- Challenges in validating candidate therapeutic targets in cancer
- (2018) Jeffrey Settleman et al. eLife
- MELK expression correlates with tumor mitotic activity but is not required for cancer growth
- (2018) Christopher J Giuliano et al. eLife
- Reproducibility vs. Replicability: A Brief History of a Confused Terminology
- (2018) Hans E. Plesser Frontiers in Neuroinformatics
- Transgenic Mouse Models in Cancer Research
- (2018) Ursa Lampreht Tratar et al. Frontiers in Oncology
- CRISPR/Cas9-mediated genome editing induces exon skipping by complete or stochastic altering splicing in the migratory locust
- (2018) Dafeng Chen et al. BMC BIOTECHNOLOGY
- How selective are pharmacological inhibitors of cell cycle-regulating cyclin-dependent kinases?
- (2018) Radek Jorda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Genetic and transcriptional evolution alters cancer cell line drug response
- (2018) Uri Ben-David et al. NATURE
- Cas9 immunity creates challenges for CRISPR gene editing therapies
- (2018) Julie M. Crudele et al. Nature Communications
- CRISPR/Cas9-mediated genome editing induces gene knockdown by altering the pre-mRNA splicing in mice
- (2018) Ji-Xin Tang et al. BMC BIOTECHNOLOGY
- Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
- (2018) Kendall R. Sanson et al. Nature Communications
- CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
- (2018) Karol Szlachta et al. Nature Communications
- CD95/Fas ligand mRNA is toxic to cells
- (2018) Will Putzbach et al. eLife
- Patient-derived organoids: a promising model for personalized cancer treatment
- (2018) Huayu Yang et al. Gastroenterology Report
- Patient-derived xenografts undergo mouse-specific tumor evolution
- (2017) Uri Ben-David et al. NATURE GENETICS
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- Non-homologous DNA end joining and alternative pathways to double-strand break repair
- (2017) Howard H. Y. Chang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Rapid generation of drug-resistance alleles at endogenous loci using CRISPR-Cas9 indel mutagenesis
- (2017) Jonathan J. Ipsaro et al. PLoS One
- Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression
- (2017) Joseph Rosenbluh et al. Nature Communications
- Development of a 3D angiogenesis model to study tumour – endothelial cell interactions and the effects of anti-angiogenic drugs
- (2017) Arno Amann et al. Scientific Reports
- Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism
- (2017) William Putzbach et al. eLife
- Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine
- (2016) Maximilian W. Popp et al. CELL
- Drugging the addict: non‐oncogene addiction as a target for cancer therapy
- (2016) Remco Nagel et al. EMBO REPORTS
- Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival
- (2016) Jason G. Kettle et al. JOURNAL OF MEDICINAL CHEMISTRY
- High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
- (2016) Benjamin P. Kleinstiver et al. NATURE
- CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes
- (2016) Bastiaan Evers et al. NATURE BIOTECHNOLOGY
- Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes
- (2016) David W Morgens et al. NATURE BIOTECHNOLOGY
- Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array
- (2016) Bernd Zetsche et al. NATURE BIOTECHNOLOGY
- Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells
- (2016) Gaelen T Hess et al. NATURE METHODS
- CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells
- (2016) S. John Liu et al. SCIENCE
- CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions
- (2016) D. M. Munoz et al. Cancer Discovery
- Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
- (2016) A. J. Aguirre et al. Cancer Discovery
- Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening
- (2016) Carla S Verissimo et al. eLife
- An Inducible System for Rapid Degradation of Specific Cellular Proteins Using Proteasome Adaptors
- (2016) Shameika R. Wilmington et al. PLoS One
- Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance
- (2015) M. D. Gurden et al. CANCER RESEARCH
- Natural Variation in Gene Expression Modulates the Severity of Mutant Phenotypes
- (2015) Victoria Vu et al. CELL
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
- (2015) Chi-Ping Day et al. CELL
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
- (2015) A. Goodspeed et al. MOLECULAR CANCER RESEARCH
- Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
- (2015) Michael Boettcher et al. MOLECULAR CELL
- Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
- (2015) Junwei Shi et al. NATURE BIOTECHNOLOGY
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- The promise and peril of chemical probes
- (2015) Cheryl H Arrowsmith et al. Nature Chemical Biology
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- An analysis of the attrition of drug candidates from four major pharmaceutical companies
- (2015) Michael J. Waring et al. NATURE REVIEWS DRUG DISCOVERY
- High-throughput functional genomics using CRISPR–Cas9
- (2015) Ophir Shalem et al. NATURE REVIEWS GENETICS
- Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogation
- (2015) Antonia A. Dominguez et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
- (2015) YOSHINORI IMAMURA et al. ONCOLOGY REPORTS
- The siRNA Non-seed Region and Its Target Sequences Are Auxiliary Determinants of Off-Target Effects
- (2015) Piotr J. Kamola et al. PLoS Computational Biology
- Modeling human carcinomas: Physiologically relevant 3D models to improve anti-cancer drug development
- (2014) Christine Unger et al. ADVANCED DRUG DELIVERY REVIEWS
- The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor
- (2014) Yong-Soon Cho et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?
- (2014) Elisavet Paplomata et al. CANCER
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- A Computational Algorithm to Predict shRNA Potency
- (2014) Simon R.V. Knott et al. MOLECULAR CELL
- Measuring error rates in genomic perturbation screens: gold standards for human functional genomics
- (2014) T. Hart et al. Molecular Systems Biology
- MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
- (2014) Helge Gad et al. NATURE
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- DrugTargetSeqR: a genomics- and CRISPR-Cas9–based method to analyze drug targets
- (2014) Corynn Kasap et al. Nature Chemical Biology
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- (2013) Luke A. Gilbert et al. CELL
- High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
- (2013) Vikram Pattanayak et al. NATURE BIOTECHNOLOGY
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- CRISPR interference (CRISPRi) for sequence-specific control of gene expression
- (2013) Matthew H Larson et al. Nature Protocols
- The Tumor Microenvironment Strongly Impacts Master Transcriptional Regulators and Gene Expression Class of Glioblastoma
- (2012) Lee A.D. Cooper et al. AMERICAN JOURNAL OF PATHOLOGY
- Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
- (2012) H. Kantarjian et al. BLOOD
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Oncogene addiction
- (2012) Jeffrey Settleman CURRENT BIOLOGY
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Discovery of small molecule cancer drugs: Successes, challenges and opportunities
- (2012) Swen Hoelder et al. Molecular Oncology
- Using transcriptome sequencing to identify mechanisms of drug action and resistance
- (2012) Sarah A Wacker et al. Nature Chemical Biology
- A bioinformatics method identifies prominent off-targeted transcripts in RNAi screens
- (2012) Frederic D Sigoillot et al. NATURE METHODS
- C911: A Bench-Level Control for Sequence Specific siRNA Off-Target Effects
- (2012) Eugen Buehler et al. PLoS One
- STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability
- (2012) T. Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells
- (2012) Michel Weïwer et al. ACS Medicinal Chemistry Letters
- STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells
- (2011) C. Babij et al. CANCER RESEARCH
- Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma
- (2011) J. J. Luke et al. CLINICAL CANCER RESEARCH
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Probing the Probes: Fitness Factors For Small Molecule Tools
- (2010) Paul Workman et al. CHEMISTRY & BIOLOGY
- Collaboration and competition between DNA double-strand break repair pathways
- (2010) Elizabeth M. Kass et al. FEBS LETTERS
- The art of the chemical probe
- (2010) Stephen V Frye Nature Chemical Biology
- Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
- (2009) Claudia Scholl et al. CELL
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs
- (2009) Aly A Khan et al. NATURE BIOTECHNOLOGY
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
- (2009) Aimee L. Jackson et al. NATURE REVIEWS DRUG DISCOVERY
- Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer
- (2009) J Mullenders et al. ONCOGENE
- The art and design of genetic screens: RNA interference
- (2008) Michael Boutros et al. NATURE REVIEWS GENETICS
- Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening
- (2008) J. M. Silva et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started